MDR - Comprehensive Primary Revision Stems PMCF
← catalyst calendarNCT06788717 · readout ≤ 3,268 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
59estimated
Sites
2
Countries
Denmark, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-06-19 | actual | When the study began enrolling |
| Primary completion | Jul 2035 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2040 | estimated | The whole study's end, after follow-up |
| First posted | 2025-01-23 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Shoulder Pain
- Shoulder Injuries
- Shoulder Fractures
- Shoulder Disease
- Shoulder Arthritis
Intervention
- Device: Comprehensive Primary Revision Stems
Primary outcomes
what the primary-completion date above is the date OFImplant Survivorship at 10 years follow-up (Kaplan Meier)
measured 10 years
Frequency and Incidence of Adverse Events (Safety)
measured 10 years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed